Last reviewed · How we verify
Concomitant administration of EV71vaccine with EPI vaccines — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Concomitant administration of EV71vaccine with EPI vaccines (Concomitant administration of EV71vaccine with EPI vaccines) — Sinovac Biotech Co., Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Concomitant administration of EV71vaccine with EPI vaccines TARGET | Concomitant administration of EV71vaccine with EPI vaccines | Sinovac Biotech Co., Ltd | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Concomitant administration of EV71vaccine with EPI vaccines CI watch — RSS
- Concomitant administration of EV71vaccine with EPI vaccines CI watch — Atom
- Concomitant administration of EV71vaccine with EPI vaccines CI watch — JSON
- Concomitant administration of EV71vaccine with EPI vaccines alone — RSS
Cite this brief
Drug Landscape (2026). Concomitant administration of EV71vaccine with EPI vaccines — Competitive Intelligence Brief. https://druglandscape.com/ci/concomitant-administration-of-ev71vaccine-with-epi-vaccines. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab